Trial · NCT04755283
Participant flow12
How many started, completed or left each group, period by period.
1 to 12 of 12
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Abelacimab 90 mg (MAA868) | 427 | |
| Overall Study | STARTED | Abelacimab 150 mg (MAA868) | 430 | |
| Overall Study | STARTED | Rivaroxaban | 430 | |
| Overall Study | Entered Open-Label | Abelacimab 90 mg (MAA868) | 250 | |
| Overall Study | Entered Open-Label | Abelacimab 150 mg (MAA868) | 240 | |
| Overall Study | Entered Open-Label | Rivaroxaban | 215 | |
| Overall Study | COMPLETED | Abelacimab 90 mg (MAA868) | 382 | |
| Overall Study | COMPLETED | Abelacimab 150 mg (MAA868) | 391 | |
| Overall Study | COMPLETED | Rivaroxaban | 389 | |
| Overall Study | NOT COMPLETED | Abelacimab 90 mg (MAA868) | 45 | |
| Overall Study | NOT COMPLETED | Abelacimab 150 mg (MAA868) | 39 | |
| Overall Study | NOT COMPLETED | Rivaroxaban | 41 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04755283/flow